Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (HKG:0874)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
19.20
-0.23 (-1.18%)
At close: Feb 13, 2026
Market Cap44.17B -0.1%
Revenue (ttm)84.74B +1.5%
Net Income3.26B -12.8%
EPS2.01 -12.8%
Shares Outn/a
PE Ratio13.53
Forward PE14.12
Dividend0.88 (4.56%)
Ex-Dividend DateAug 29, 2025
Volume458,612
Average Volume1,360,698
Open19.26
Previous Close19.43
Day's Range19.16 - 19.34
52-Week Range15.76 - 20.40
Beta0.30
RSI57.51
Earnings DateMar 21, 2026

About HKG:0874

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited researches, develops, manufactures, and sells Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials. The company operates through Great Southern TCM, Great Commerce, Great Health, and Other segments. It is also involved in the wholesale, retail, sale, import, and export of Western and Chinese medicines, medical instruments, pharmaceutical products, medical apparatus, and healthcare products; research... [Read more]

Sector Healthcare
Founded 1997
Employees 27,425
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 0874
Full Company Profile

Financial Performance

In 2024, HKG:0874's revenue was 74.99 billion, a decrease of -0.69% compared to the previous year's 75.52 billion. Earnings were 2.84 billion, a decrease of -30.09%.

Financial numbers in CNY Financial Statements